ImmunAdd aims to develop next generation adjuvants which are designed to provide better immune-activities in combining with various vaccines and to have better tolerability. Consistently, and especially in the near term pipelines, ImmunAdd has developed an efficient and sustainable manufacturing process to IA05. With POC purpose, ImmunAdd will continue to expand our development to clinical-stage programs.